BelgiumOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1,369 out of 212,967 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 33,880 | 38,055 |
| Total Cites | 8,541 | 9,182 |
| H-index | 40 | 41 |
| Hm-index | 25 | 26 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 684 | 700 |
| Number of Single+First Authored Papers | 70 | 70 |
| Total Cites to Single+First Authored Papers | 2,746 | 2,847 |
| Number of Single+First+Last Authored Papers | 170 | 170 |
| Total Cites to Single+First+Last Authored Papers | 6,246 | 6,718 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7,329 | 7,616 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.21 |
| Self-Citation Percentage |
6.98%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1,454 out of 208,384 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 34,739 | 38,097 |
| Total Cites | 7,918 | 8,544 |
| H-index | 38 | 40 |
| Hm-index | 23 | 25 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 636 | 652 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 2,608 | 2,708 |
| Number of Single+First+Last Authored Papers | 169 | 169 |
| Total Cites to Single+First+Last Authored Papers | 5,922 | 6,384 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,801 | 7,079 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.21 |
| Self-Citation Percentage |
7.33%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1,523 out of 204,091 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35,135 | 38,758 |
| Total Cites | 7,301 | 7,916 |
| H-index | 37 | 39 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 582 | 598 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 2,466 | 2,566 |
| Number of Single+First+Last Authored Papers | 169 | 169 |
| Total Cites to Single+First+Last Authored Papers | 5,607 | 6,063 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,273 | 6,543 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.21 |
| Self-Citation Percentage |
7.77%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1,596 out of 201,173 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35,112 | 38,767 |
| Total Cites | 6,705 | 7,303 |
| H-index | 36 | 39 |
| Hm-index | 22 | 22 |
| Number of Single Authored Papers | 27 | 27 |
| Total Cites to Single Authored Papers | 515 | 530 |
| Number of Single+First Authored Papers | 68 | 68 |
| Total Cites to Single+First Authored Papers | 2,308 | 2,402 |
| Number of Single+First+Last Authored Papers | 167 | 167 |
| Total Cites to Single+First+Last Authored Papers | 5,259 | 5,696 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5,774 | 6,050 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.21 |
| Self-Citation Percentage |
8.19%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.